Sort
48,018 grants matching “immunotherapy”
Novel Targets for Vaccine Therapy
$848,816Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$848,658Alan David Levine · Case Western Reserve University · R01 · FY2019 · DA
Xenogeneic Stem Cell and Thymic Replacement in AIDS
$848,198Massachusetts General Hospital · P01 · FY2002 · AI
Antibody Based Therapeuticcs for Chikungunya Virus
$848,100Michael S. Diamond · Washington University · R01 · FY2010 · AI
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
$848,075Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2024 · CA
Immunologic correlates of functional cure of HBV with immune checkpoint blockade
$847,913Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2020 · AI
Rapid highly multi-plexed immuno-profiling of solid tumors by SpectralEdge imaging
$847,774Eric Kaldjian · Rarecyte, Inc. · R44 · FY2021 · CA
Preclinical Development of a Novel and Powerful Immunotherapeutic
$847,617Susan Dana Jones · Immurx Llc · R44 · FY2012 · AI
Northern California Pediatrics AIDS Treatment Center
$847,590University Of California San Francisco · U01 · FY2002 · AI
First-in-human study of a potent anti-HBsAg neutralizing antibody
$847,498Marina Caskey · Rockefeller University · U01 · FY2024 · AI
Immune Control and Evasion during Acute HCV Infection
$847,330Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2013 · AI
Core A:Administrative Core
$847,090Timothy P Cripe · Research Inst Nationwide Children'S Hosp · U54 · FY2019 · CA
Pathogenesis and Treatment of Anaphylaxis
$847,026Dean D Metcalfe · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Vaccine and Drug Combination Therapy for Human Cancers
$847,016James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Vaccine and radiation for the therapy of human cancers
$847,016James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
CANCER THERAPY WITH ACTIVATED NATURAL KILLER CELLS
$847,008University Of Pittsburgh At Pittsburgh · P01 · FY2000 · CA
Navigating Pathways of Innate Immunity and Epigenetic Memory in Checkpoint Immunotherapy
$846,982Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R35 · FY2025 · CA
Defining the Mechanisms of Immune Escape After Adoptive T cell Therapies
$846,699Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2024 · CA
Novel Approach to High-Throughput Identification and Characterization of Neoantigen-Specific T-Cell Receptors to Guide Immunotherapy Development.
$846,678Magali Soumillon · Flexomics Llc · R44 · FY2023 · CA
Mechanism of Epigenetic Inheritance
$846,662Zhiguo Zhang · Columbia University Health Sciences · R35 · FY2024 · GM
Mechanism of Epigenetic Inheritance
$846,662Zhiguo Zhang · Columbia University Health Sciences · R35 · FY2025 · GM
Mechanism of Epigenetic Inheritance
$846,662Zhiguo Zhang · Columbia University Health Sciences · R35 · FY2022 · GM
Mechanism of Epigenetic Inheritance
$846,662Zhiguo Zhang · Columbia University Health Sciences · R35 · FY2023 · GM
Mechanism of Epigenetic Inheritance
$846,662Zhiguo Zhang · Columbia University Health Sciences · R35 · FY2021 · GM
Development of highly neutralizing nanobodies against HIV-1, SARS-CoV-2 and other pathogens
$846,518Rafael C Casellas · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR